|
Slutzman JE, Curley DP, Macias-Konstantopoulos W, Brown DF.
"Altered mental status and tachycardia." The Journal of Emergency Medicine, vol. 48, no. 5, 2015, pp. 597-602.
|
|
Venkatesh, Arjun K., Curley, David, Chang, Yuchiao, Liu, Shan W.
"Communication of Vital Signs at Emergency Department Handoff: Opportunities for Improvement." Annals of Emergency Medicine, vol. 66, no. 2, 2015, pp. 125-130.
|
|
Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, Zaidi MR, Tighe S, Davies MA, Dankort D, McMahon M, Merlino G, Bardeesy N, Bosenberg M.
"mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation." Cancer Cell, vol. 27, no. 1, 2015, pp. 41-56.
|
|
Sri-On J, Chang Y, Curley DP, Camargo CA Jr, Weissman JS, Singer SJ, Liu SW.
"Boarding is associated with higher rates of medication delays and adverse events but fewer laboratory-related delays." The American Journal of Emergency Medicine, vol. 32, no. 9, 2014, pp. 1033-6.
|
|
Alvarez V, Westover MB, Drislane FW, Dworetzky BA, Curley D, Lee JW, Rossetti AO.
"Evaluation of a clinical tool for early etiology identification in status epilepticus." Epilepsia, vol. 55, no. 12, 2014, pp. 2059-2068.
|
|
Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE, Taketo MM, Dankort D, Rimm DL, McMahon M, Bosenberg M.
"β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas." Cancer Cell, vol. 20, no. 6, 2011, pp. 741-54.
|
|
Held MA, Curley DP, Dankort D, McMahon M, Muthusamy V, Bosenberg MW.
"Characterization of melanoma cells capable of propagating tumors from a single cell." Cancer Research, vol. 70, no. 1, 2010, pp. 388-97.
|
|
Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr, You MJ, DePinho RA, McMahon M, Bosenberg M.
"Braf(V600E) cooperates with Pten loss to induce metastatic melanoma." Nature Genetics, vol. 41, no. 5, 2009, pp. 544-52.
|
|
Curley DP, Bosenberg MW.
"A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin." Pigment Cell & Melanoma Research, vol. 21, no. 1, 2008, pp. 5-6.
|
|
Yang G, Curley D, Bosenberg MW, Tsao H.
"Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice." Cancer Research, vol. 67, no. 12, 2007, pp. 5649-57.
|
|
Bosenberg M, Muthusamy V, Curley DP, Wang Z, Hobbs C, Nelson B, Nogueira C, Horner JW 2nd, Depinho R, Chin L.
"Characterization of melanocyte-specific inducible Cre recombinase transgenic mice." genesis, vol. 44, no. 5, 2006, pp. 262-7.
|
|
Muthusamy V, Duraisamy S, Bradbury CM, Hobbs C, Curley DP, Nelson B, Bosenberg M.
"Epigenetic silencing of novel tumor suppressors in malignant melanoma." Cancer Research, vol. 66, no. 23, 2006, pp. 11187-93.
|
|
Lee BH, Williams IR, Anastasiadou E, Boulton CL, Joseph SW, Amaral SM, Curley DP, Duclos N, Huntly BJ, Fabbro D, Griffin JD, Gilliland DG.
"FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model." Oncogene, vol. 24, no. 53, 2005, pp. 7882-92.
|
|
Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R, Curley DP, Kutok JL, Akashi K, Williams IR, Speck NA, Gilliland DG.
"Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype." Blood, vol. 106, no. 2, 2005, pp. 494-504.
|
|
Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Amaral S, Curley D, Williams IR, Akashi K, Gilliland DG.
"MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors." Cancer Cell, vol. 6, no. 6, 2004, pp. 587-96.
|
|
Clark JJ, Cools J, Curley DP, Yu JC, Lokker NA, Giese NA, Gilliland DG.
"Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518." Blood, vol. 104, no. 9, 2004, pp. 2867-72.
|
